SCANTECH AI SYSTEMS INC (STAI) Fundamental Analysis & Valuation

NASDAQ:STAIUS80603V2034

Current stock price

0.9001 USD
-0.59 (-39.59%)
At close:
0.6252 USD
-0.27 (-30.54%)
After Hours:

This STAI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. STAI Profitability Analysis

1.1 Basic Checks

  • STAI had positive earnings in the past year.
  • In the past year STAI has reported a negative cash flow from operations.
STAI Yearly Net Income VS EBIT VS OCF VS FCFSTAI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 -5M -10M -15M -20M

1.2 Ratios

  • With a Return On Assets value of -174.36%, STAI is not doing good in the industry: 93.50% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -174.36%
ROE N/A
ROIC N/A
ROA(3y)-356.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
STAI Yearly ROA, ROE, ROICSTAI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -200 -400 -600 -800 -1K

1.3 Margins

  • Looking at the Gross Margin, with a value of 29.93%, STAI is in line with its industry, outperforming 47.97% of the companies in the same industry.
  • The Profit Margin and Operating Margin are not available for STAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
STAI Yearly Profit, Operating, Gross MarginsSTAI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 -1K -2K -3K -4K

0

2. STAI Health Analysis

2.1 Basic Checks

  • STAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, STAI has less shares outstanding
  • STAI has a worse debt/assets ratio than last year.
STAI Yearly Shares OutstandingSTAI Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2M 4M 6M 8M
STAI Yearly Total Debt VS Total AssetsSTAI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.06%
STAI Yearly LT Debt VS Equity VS FCFSTAI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 50M -50M -100M -150M

2.3 Liquidity

  • STAI has a Current Ratio of 0.18. This is a bad value and indicates that STAI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of STAI (0.18) is worse than 95.12% of its industry peers.
  • STAI has a Quick Ratio of 0.18. This is a bad value and indicates that STAI is not financially healthy enough and could expect problems in meeting its short term obligations.
  • STAI has a Quick ratio of 0.12. This is amonst the worse of the industry: STAI underperforms 95.12% of its industry peers.
Industry RankSector Rank
Current Ratio 0.18
Quick Ratio 0.12
STAI Yearly Current Assets VS Current LiabilitesSTAI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 50M 100M 150M

1

3. STAI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 144.94% over the past year.
EPS 1Y (TTM)144.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
STAI Yearly Revenue VS EstimatesSTAI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2024 100K 200K 300K 400K 500K

2

4. STAI Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 0.08, the valuation of STAI can be described as very cheap.
  • Based on the Price/Earnings ratio, STAI is valued cheaper than 100.00% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.89. STAI is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 0.08
Fwd PE N/A
STAI Price Earnings VS Forward Price EarningsSTAI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
STAI Per share dataSTAI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. STAI Dividend Analysis

5.1 Amount

  • No dividends for STAI!.
Industry RankSector Rank
Dividend Yield 0%

STAI Fundamentals: All Metrics, Ratios and Statistics

SCANTECH AI SYSTEMS INC

NASDAQ:STAI (2/9/2026, 8:00:01 PM)

After market: 0.6252 -0.27 (-30.54%)

0.9001

-0.59 (-39.59%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A
Earnings (Next)05-12
Inst Owners27%
Inst Owner Change0%
Ins Owners7.97%
Ins Owner Change0%
Market Cap67.62M
Revenue(TTM)1.88M
Net Income(TTM)-8.97M
AnalystsN/A
Price TargetN/A
Short Float %0.04%
Short Ratio0.02
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.08
Fwd PE N/A
P/S 35.95
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)10.8
EY1199.87%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.03
BVpS-0.55
TBVpS-0.55
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -174.36%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.93%
FCFM N/A
ROA(3y)-356.37%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.37
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 54.75%
Cap/Sales 0.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.18
Quick Ratio 0.12
Altman-Z N/A
F-Score4
WACC9.06%
ROIC/WACCN/A
Cap/Depr(3y)40.84%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)144.94%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%86.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-487.37%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-792.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-790.15%
OCF growth 3YN/A
OCF growth 5YN/A

SCANTECH AI SYSTEMS INC / STAI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for SCANTECH AI SYSTEMS INC?

ChartMill assigns a fundamental rating of 1 / 10 to STAI.


What is the valuation status for STAI stock?

ChartMill assigns a valuation rating of 2 / 10 to SCANTECH AI SYSTEMS INC (STAI). This can be considered as Overvalued.


How profitable is SCANTECH AI SYSTEMS INC (STAI) stock?

SCANTECH AI SYSTEMS INC (STAI) has a profitability rating of 1 / 10.


Can you provide the PE and PB ratios for STAI stock?

The Price/Earnings (PE) ratio for SCANTECH AI SYSTEMS INC (STAI) is 0.08 and the Price/Book (PB) ratio is -1.64.


What is the financial health of SCANTECH AI SYSTEMS INC (STAI) stock?

The financial health rating of SCANTECH AI SYSTEMS INC (STAI) is 0 / 10.